Evidence map›Paper›PMID 30815503›Full record

ArticleOpen forum infectious diseases2019

A Lower Dose of Efavirenz Can Be Coadministered With Rifampicin and Isoniazid in Tuberculosis Patients.

Julian P Kaboggoza, Xinxhu Wang, Megan Neary, Pedro Ayuso, Christine Sekaggya-Wiltshire, Shadia Nakalema, Andrew Owen, Myra McClure, Mohammed Lamorde, Marta Boffito

Abstract read
In one paragraph

Article in Open forum infectious diseases, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Julian P KaboggozaInfectious Diseases Institute, Makerere University College of Health Sciences, Mulago Hospital Complex, Kampala, Uganda.ORCID 0000-0001-9510-0474
Xinxhu WangJeffriess Research Trust Laboratories, Department of Medicine, Imperial College, London, United Kingdom.
Megan NearyMolecular and Clinical Pharmacology, Institute of Translational Medicine, University of Liverpool, United Kingdom.
Pedro AyusoMolecular and Clinical Pharmacology, Institute of Translational Medicine, University of Liverpool, United Kingdom.
Christine Sekaggya-WiltshireInfectious Diseases Institute, Makerere University College of Health Sciences, Mulago Hospital Complex, Kampala, Uganda.
Shadia NakalemaInfectious Diseases Institute, Makerere University College of Health Sciences, Mulago Hospital Complex, Kampala, Uganda.
Andrew OwenMolecular and Clinical Pharmacology, Institute of Translational Medicine, University of Liverpool, United Kingdom.
Myra McClureJeffriess Research Trust Laboratories, Department of Medicine, Imperial College, London, United Kingdom.
Mohammed LamordeInfectious Diseases Institute, Makerere University College of Health Sciences, Mulago Hospital Complex, Kampala, Uganda.
Marta BoffitoJeffriess Research Trust Laboratories, Department of Medicine, Imperial College, London, United Kingdom.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

HIVisoniazid/rifampicinlow-dose efavirenzpharmacokineticstuberculosis

Identifiers

PMID30815503
PMCPMC6386798

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.